Crossmark

Response to “Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis”. Response to related letter

Crossref DOI link: https://doi.org/10.1016/j.nefroe.2023.10.010

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

De La Flor, José C.

Moral, Esperanza

Deira, Javier

Monzón, Tania

Valga, Francisco

Albarracín, Cristina

Rodeles, Miguel
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-06-04
More Information

This article is maintained by: Elsevier

Article Title: Response to “Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis”. Response to related letter

Journal Title: Nefrología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefroe.2023.10.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nefro.2023.10.005

Content Type: simple-article

Copyright: © 2020 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.